Filter By Year:
Filter By Topic:
June 2021 - Therapies against endogenous retroviruses and their relationship with persistent covid, among the advances of the Gene Expression and Immunity Group
EMERG member from Spain, Professor Elisa Oltra, presented at the #BRMEC10 Colloquium recently.
The Gene Expression and Immunity research group of the Faculty of Medicine and Health Sciences of the Catholic University of Valencia (UCV),
where Elisa is the principal investigator,
recently discussed her work and that of UCV research group member Karen Giménez.
June 2021 - EMERG and International ME Colloquium
EMERG played a major part in the recent 10th Invest in ME Research International Biomedical Research into ME Colloquium #BRMEC10
that was held recently.
The main part of the agenda was formulated by EMERG in collaboration with the UK charity.
A report will be available from the Invest in ME Research web site. More information will be in the EMERG site in due course.
June 2020 - Netherlands to Fund Biomedical Research
A proposed research agenda has been submitted to the Dutch Minister of Health and includes research funding of € 20-29½ million over 10 years for a biomedical research program.Read More
January 2020 - The Prevalence of Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community-Based Sample
The prevalence of pediatric #mecfs 0.75%, a higher percentage being African American and Latinx than Caucasian. Less than 5% had been previously diagnosed with the illness. Jason, L.A., Katz, B.Z., Sunnquist, M. et al. Child Youth Care Forum (2020).Read More
June 2019 - EMECC to present at EAN Congress
Members of the The European ME Alliance (EMEA) have been working with European Federation of Neurological Associations (EFNA) to set up an awareness day for ME at the upcoming European Academy of Neurology Congress in Norway.Read More